# FDA Inspection 1035452 - Cebiphar - September 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/cebiphar/0622d910-cc7c-461e-a0ab-202edfdbc1d7
Source feed: FDA_Inspections

> FDA Inspection 1035452 for Cebiphar on September 27, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1035452
- Company Name: Cebiphar
- Inspection Date: 2017-09-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1190271 - 2019-05-10](https://www.keypedia.com/records/fda_inspections/cebiphar/22d76c19-9ae2-49f1-9802-7fd31046d0db)
- [FDA Inspection 932063 - 2015-06-16](https://www.keypedia.com/records/fda_inspections/cebiphar/107e42fe-530f-44cd-9584-f2b84743693f)
- [FDA Inspection 648221 - 2010-02-03](https://www.keypedia.com/records/fda_inspections/cebiphar/263dbfa3-383f-4cbf-94c7-d6c01fab1423)

Company: https://www.keypedia.com/companies/cebiphar/be59f61f-8d92-46b2-b240-cd082265803f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c